CVE-2026-123050

7.1High

Published 17 Nov 2026 · NVD status: Received · AI triage by gemini-3.1-flash-lite

7.1CVSS

High

0CVSS v4.010

Attack vector
Network
Complexity
High
Privileges
None
User action
None
Impact
High impact on confidentiality, integrity
Weakness
CWE-295

What an attacker gets

Attackers can intercept and modify sensitive healthcare data by impersonating trusted services. This requires the attacker to perform a man-in-the-middle attack on network traffic.

Root cause

The application fails to properly validate TLS certificates during network communication.

Affected versions

Versions not listed — check the vendor advisory.

CVSS v4.0 · CVSS:4.0/AV:N/AC:H/AT:N/PR:N/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N/E:U/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Fix & remediation

Check the vendor advisory for the latest patched version and update immediately. If patching is delayed, ensure all traffic is restricted to trusted, encrypted VPN tunnels or private circuits to prevent interception.

AI-suggested. Run it in staging first and check it against the vendor advisory. Why?

NVD description

Multiple Farmasimplex healthcare integration modules do not properly validate TLS certificates, allowing an attacker who can intercept network traffic to impersonate trusted healthcare services and perform man-in-the-middle attacks, potentially leading to disclosure or modification of sensitive data.

References

Source: nvd.nist.gov/vuln/detail/CVE-2026-123050